Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1AMERICAN JOURNAL OF TRANSPLANTATIONIF8.22024-11-011OA
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse eventsSCIENCE TRANSLATIONAL MEDICINEIF14.62023-02-0115PRE
Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC PolyomavirusesIMMUNITYIF26.32019-03-0145OAAI